Dysfunctional VoidingNCT07149532
Standard Urotherapy for Dysfunctional Voiding in Children
A study testing Standard urotherapy (SUT) alone. in people with Dysfunctional Voiding and Medical Treatment, run by Tanta University at 1 site in Egypt.
Trial summary
This study aims to assess the efficiency of the standard urotherapy for the management of dysfunctional voiding in children. Read more about this study
- Who is it for?
- Ages Up to 18 years
- Conditions the study is for
- Dysfunctional Voiding, Medical Treatment, Children
- What is being tested?
- Standard urotherapy (SUT) alone.
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 140 participants
- Where
- 1 siteEgypt
- Study dates
- 26 Feb 2025to 1 Apr 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Up to 18 years
- All sexes
- No healthy volunteers
- Child, Adult
Who may be able to join
- Children less than 18 years old.
- Both sexes.
- Children with dysfunctional voiding.
Who cannot join
- Patients with cognitive function impairment.
- Patients who received any care for dysfunctional voiding.
- Children with known anatomical anomalies of the urinary tract.
- Children with known neurological anomalies (spinal dysraphism, multiple sclerosis, lumbar or spinal neuritis……… etc).
- Children with a history of back or lower urinary tract trauma.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Standard Urotherapy for Dysfunctional Voiding in Children: A Randomized Clinical Study
This study aims to assess the efficiency of the standard urotherapy for the management of dysfunctional voiding in children.
Read the detailed description
Dysfunctional voiding (DV) in children may result in lower urinary tract symptoms (LUTS), such as urgency, frequency, urinary incontinence, and difficulty in urination.
- Conditions
- Dysfunctional Voiding, Medical Treatment, Children
- Being tested
- Standard urotherapy (SUT) alone., Sham control
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Standard urotherapy (SUT) alone.Behavioural
Patients will receive the standard urotherapy (SUT) alone.
Sham controlOther
Sham control
| Study group | Role | What they receive |
|---|---|---|
| Group 1 | Active comparator | Patients will receive the standard urotherapy (SUT) . Receives: Behavioral: Standard urotherapy (SUT) alone. |
| Group 2 | Sham comparator | Patients will receive nothing Receives: Other: Sham control |
What is being measured
The primary outcome is the main question the study is designed to answer.
Overall response rate
Overall response rate will be recorded.
Measured: 6 months post-procedure
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Sep 2025
- Study start26 Feb 2025
- Primary completion1 Apr 2026
- Study completion1 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dysfunctional VoidingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 140 participants (actual)
Sponsor and investigators
- Lead sponsor
- Tanta University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mohamed Ibrahim Ahmed Elmaadawy, Tanta University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07149532
- Sponsor's protocol ID
- PRS213465
- Status last verified
- Jul 2026
- First submitted
- 24 Aug 2025
- Last updated
- 3 Aug 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Study at a glance
From the registry record, last updated by the sponsor on 3 Aug 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Standard Urotherapy for Dysfunctional Voiding in Children: A Randomized Clinical Study
- ClinicalTrials.gov ID
- NCT07149532
- Acronym / sponsor ID
- PRS213465
- Conditions
- Dysfunctional Voiding, Medical Treatment, Children
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 140 participants (actual)
- Lead sponsor
- Tanta UniversityUniversity, hospital or other
- Study start
- 26 Feb 2025 (actual)
- Primary completion
- 1 Apr 2026 (actual)
- Study completion
- 1 Apr 2026 (actual)
- First posted
- 2 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to assess the efficiency of the standard urotherapy for the management of dysfunctional voiding in children.
Detailed description
Dysfunctional voiding (DV) in children may result in lower urinary tract symptoms (LUTS), such as urgency, frequency, urinary incontinence, and difficulty in urination.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group 1 | Active comparator | Behavioral: Standard urotherapy (SUT) alone.Patients will receive the standard urotherapy (SUT) . |
| Group 2 | Sham comparator | Other: Sham controlPatients will receive nothing |
Who may qualify
- Ages
- Up to 18 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
Key inclusion criteria (3 listed)
- Children less than 18 years old.
- Both sexes.
- Children with dysfunctional voiding.
Key exclusion criteria (5 listed)
- Patients with cognitive function impairment.
- Patients who received any care for dysfunctional voiding.
- Children with known anatomical anomalies of the urinary tract.
- Children with known neurological anomalies (spinal dysraphism, multiple sclerosis, lumbar or spinal neuritis……… etc).
- Children with a history of back or lower urinary tract trauma.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Standard urotherapy (SUT) alone.Patients will receive the standard urotherapy (SUT) alone. | Behavioural | Group 1 |
| Sham controlSham control | Other | Group 2 |
Primary outcome
Overall response rate
Time frame: 6 months post-procedure
Overall response rate will be recorded.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Aug 2026.
- Individual participant dataSharing planned: Yes. The data will be available upon a reasonable request from the corresponding author after the end of study for one year.
Related trials for Dysfunctional Voiding
Recruiting
Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis
Local Injection, Botulinium Toxin-A
Active, not recruitingObservational study
Biofeedback for Dysfunctional Voiding and Giggle Incontinence
Biofeedback Therapy, Dysfunctional Voiding
Not yet recruiting
Use of an Educational Video to Improve Adherence to Treatment in Voiding Dysfunction
Dysfunctional Voiding
Not yet recruitingObservational study
Case Control Study to Investigate the Use of Urethral Pressure Profile Measurement in Children
Dysfunctional Voiding, Stress Incontinence, Urinary
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Standard urotherapy (SUT) alone. in people with Dysfunctional Voiding and Medical Treatment, run by Tanta University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Overall response rate (time frame: 6 months post-procedure). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2026.